Multiple sclerosis: basic knowledge and new insights in perioperative management (Q38130445)

29 August 2017

title

Multiple sclerosis: basic knowledge and new insights in perioperative management (English)

1 reference

29 August 2017

0 references

Alexandros Makris

1

1 reference

29 August 2017

Alexandros Piperopoulos

series ordinal

2

1 reference

29 August 2017

Iosifina Karmaniolou

series ordinal

3

1 reference

29 August 2017

publication date

21 August 2013

1 reference

29 August 2017

published in

Journal of Anesthesia

1 reference

29 August 2017

volume

28

1 reference

29 August 2017

issue

2

1 reference

29 August 2017

page(s)

267-278

1 reference

https://api.crossref.org/works/10.1007%2FS00540-013-1697-2

29 August 2017

1 reference

The prevalence of multiple sclerosis in the world: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00540-013-1697-2

The changing demographic pattern of multiple sclerosis epidemiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00540-013-1697-2

Age at disability milestones in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00540-013-1697-2

Cost-Effectiveness of Disease-Modifying Therapies in Multiple Sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00540-013-1697-2

Symptomatology of MS: results from the German MS Registry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00540-013-1697-2

Mechanisms underlying muscle fatigue differ between multiple sclerosis patients and controls: a combined electrophysiological and neuroimaging study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00540-013-1697-2

Depression in multiple sclerosis: a review of assessment and treatment approaches in adult and pediatric populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00540-013-1697-2

A mechanism-based classification of pain in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00540-013-1697-2

Reappraisal of Lhermitte's sign in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00540-013-1697-2

Multiple sclerosis: a disease of affluence?.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00540-013-1697-2

Relation between Epstein-Barr virus and multiple sclerosis: analytic study of scientific production

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00540-013-1697-2

A functional and structural basis for TCR cross-reactivity in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00540-013-1697-2

Parental smoking at home and the risk of childhood-onset multiple sclerosis in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00540-013-1697-2

Clinical implications of a possible role of vitamin D in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00540-013-1697-2

Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00540-013-1697-2

The causal cascade to multiple sclerosis: a model for MS pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00540-013-1697-2

Exposure to anaesthetic agents does not affect multiple sclerosis risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00540-013-1697-2

Role of the innate immune system in the pathogenesis of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00540-013-1697-2

Multiple sclerosis: pathogenesis and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00540-013-1697-2

Sensitivity to heat in MS patients: a factor strongly influencing symptomology--an explorative survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00540-013-1697-2

Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00540-013-1697-2

Multiple sclerosis: current treatment algorithms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00540-013-1697-2

In vitro evidence that subcutaneous administration of glatiramer acetate induces hyporesponsive T cells in patients with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00540-013-1697-2

Treatment of relapsing–remitting multiple sclerosis with high-dose cyclophosphamide induction followed by glatiramer acetate maintenance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00540-013-1697-2

Intravenous immunoglobulin in relapsing-remitting multiple sclerosis: a dose-finding trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00540-013-1697-2

Evidence-based guideline update: Plasmapheresis in neurologic disorders: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00540-013-1697-2

4-aminopyridine toxicity: a case report and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00540-013-1697-2

Mitoxantrone as induction treatment in aggressive relapsing remitting multiple sclerosis: treatment response factors in a 5 year follow-up observational study of 100 consecutive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00540-013-1697-2

Spasticity: pathophysiology, evaluation and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00540-013-1697-2

A double-blind, randomized, placebo-controlled, parallel-group study of THC/CBD oromucosal spray in combination with the existing treatment regimen, in the relief of central neuropathic pain in patients with multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00540-013-1697-2

Liver injury associated with the beta-interferons for MS: a comparison between the three products.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00540-013-1697-2

The mechanism of action of glatiramer acetate treatment in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00540-013-1697-2

Breathlessness, night sweats, and weight loss on natalizumab

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00540-013-1697-2

Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00540-013-1697-2

Peri-operative steroid supplementation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00540-013-1697-2

Use of intravenous immunoglobulin in human disease: a review of evidence by members of the Primary Immunodeficiency Committee of the American Academy of Allergy, Asthma and Immunology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00540-013-1697-2

Complications of therapeutic plasma exchange: a prospective study of 1,727 procedures

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00540-013-1697-2

Rebound of disease activity after withdrawal of fingolimod (FTY720) treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00540-013-1697-2

Effects of multiple sclerosis on respiratory functions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00540-013-1697-2

Pulmonary function in multiple sclerosis without any respiratory complaints.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00540-013-1697-2

Is it useful to perform carbon monoxide diffusion capacity and respiratory muscle function tests in patients with multiple sclerosis without disability?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00540-013-1697-2

Sleep disturbances in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00540-013-1697-2

Nocturnal sleep study in multiple sclerosis: correlations with clinical and brain magnetic resonance imaging findings.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00540-013-1697-2

Sleep disorders in patients with multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00540-013-1697-2

Preoperative evaluation of the adult patient undergoing non-cardiac surgery: guidelines from the European Society of Anaesthesiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00540-013-1697-2

Autonomic Disorders in Multiple Sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00540-013-1697-2

Periodic hyperthermia and abnormal circadian temperature rhythm in a patient with multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00540-013-1697-2

Anesthetic management of the emergency laparotomy for a patient with multiple sclerosis -A case report-

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00540-013-1697-2

Anaesthetic management in a patient with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00540-013-1697-2

Anesthetic implications of neuromuscular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00540-013-1697-2

Desflurane anaesthesia in a patient with multiple sclerosis in total hip replacement

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00540-013-1697-2

Comparison of prophylactic use of midazolam, ketamine, and ketamine plus midazolam for prevention of shivering during regional anaesthesia: a randomized double-blind placebo controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00540-013-1697-2

Dexmedetomidine for monitored anesthesia care in patients undergoing liberation procedure for multiple sclerosis: An observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00540-013-1697-2

Anesthesia for deep brain stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00540-013-1697-2

Contemporary use and practice of electroconvulsive therapy worldwide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00540-013-1697-2

The safety and efficacy of ECT and anesthesia in the setting of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00540-013-1697-2

Anesthesia for electroconvulsive therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00540-013-1697-2

Electroconvulsive therapy increases circadian amplitude and lowers core body temperature in depressed subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00540-013-1697-2

The endogenous pentapeptide QYNAD induces acute conduction block in the isolated rat sciatic nerve.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00540-013-1697-2

An endogenous pentapeptide acting as a sodium channel blocker in inflammatory autoimmune disorders of the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00540-013-1697-2

Neuraxial anesthesia and analgesia in patients with preexisting central nervous system disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00540-013-1697-2

Rate of pregnancy-related relapse in multiple sclerosis. Pregnancy in Multiple Sclerosis Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00540-013-1697-2

Multiple sclerosis and pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00540-013-1697-2

Anesthesia for the obstetric patient with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00540-013-1697-2

Regional Anesthesia in Patients With Preexisting Neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00540-013-1697-2

Anaesthetic considerations for patients with a pre-existing neurological deficit: are neuraxial techniques safe?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00540-013-1697-2

Modifiable factors influencing relapses and disability in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00540-013-1697-2

Neuraxial anesthesia and multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00540-013-1697-2

Positive symptoms in multiple sclerosis: their treatment with sodium channel blockers, lidocaine and mexiletine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00540-013-1697-2

Disruption of central nervous system barriers in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00540-013-1697-2

Obstetric regional blocks for women with multiple sclerosis: a survey of UK experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00540-013-1697-2

Lidocaine unmasks silent demyelinative lesions in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00540-013-1697-2

Epidural blood patch in a patient with multiple sclerosis: is it safe?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00540-013-1697-2

Alteration of motor nerve recovery cycle in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00540-013-1697-2

The peripheral nervous system in multiple sclerosis. A review and pathogenetic hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00540-013-1697-2

Up-regulation of slow K(+) channels in peripheral motor axons: a transcriptional channelopathy in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00540-013-1697-2

Peripheral nerve demyelination in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00540-013-1697-2

Lower motor neuron loss in multiple sclerosis and experimental autoimmune encephalomyelitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00540-013-1697-2

Severe brachial plexopathy after an ultrasound-guided single-injection nerve block for total shoulder arthroplasty in a patient with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00540-013-1697-2

Nerve blocks, ultrasounds, and multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00540-013-1697-2

Severe brachial plexopathy after an ultrasound-guided single-injection nerve block for total shoulder arthroplasty in a patient with multiple sclerosis: what is the likely cause of this complication?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00540-013-1697-2

Prolonged duration of anesthesia in a patient with multiple sclerosis following paravertebral block

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00540-013-1697-2

Ultrasound-guided regional anesthesia and the prevention of neurologic injury: fact or fiction?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00540-013-1697-2

Natural history comparisons of primary and secondary progressive multiple sclerosis reveals differences and similarities

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00540-013-1697-2

Subclinical peripheral nervous system involvement in multiple sclerosis

21 January 2018

1 reference

12 December 2020

[Neurological deficit during recovery from cesarean section under spinal anesthesia after the appearance of undiagnosed multiple sclerosis]

1 reference

12 December 2020

Epidural anesthesia for cesarean section in a patient with von Hippel-Lindau disease and multiple sclerosis

1 reference

12 December 2020

Multiple sclerosis and anesthetic implications.

1 reference

12 December 2020

Intrathecal morphine in conjunction with a combined spinal and general anesthetic in a patient with multiple sclerosis

1 reference

12 December 2020

A 12-month follow-up for neurological complication after subarachnoid anesthesia in a parturient affected by multiple sclerosis

1 reference

12 December 2020

[Multiple sclerosis disclosed by spinal anesthesia]

1 reference

12 December 2020

10.1007/S00540-013-1697-2

Identifiers

DOI

1 reference

29 August 2017

1 reference